Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001063061 | SCV001227894 | pathogenic | not provided | 2025-01-23 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 977 of the ABCA4 protein (p.Thr977Met). This variant is present in population databases (rs148015012, gnomAD 0.09%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individuals with retinal disease (internal data). ClinVar contains an entry for this variant (Variation ID: 857398). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. This variant disrupts the p.Thr977 amino acid residue in ABCA4. Other variant(s) that disrupt this residue have been observed in individuals with ABCA4-related conditions (PMID: 19265867), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. |
| Fulgent Genetics, |
RCV005029647 | SCV005659463 | likely pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2024-06-01 | criteria provided, single submitter | clinical testing | |
| Institute of Human Genetics, |
RCV004813673 | SCV005068508 | likely pathogenic | Retinal dystrophy | 2021-01-01 | no assertion criteria provided | clinical testing |